Phase II Study of BNC210 in PTSD

PHASE2CompletedINTERVENTIONAL
Enrollment

193

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

July 5, 2018

Study Completion Date

July 25, 2018

Conditions
Post-Traumatic Stress Disorder
Interventions
DRUG

BNC210

DRUG

Placebo

Trial Locations (25)

2751

Penrith

3004

St Kilda

4066

Auchenflower

Toowong

5112

Elizabeth Vale

32256

Jacksonville

32607

Gainesville

32801

Orlando

33161

North Miami

33309

Lauderhill

33334

Oakland Park

38119

Memphis

44718

Canton

60169

Hoffman Estates

66211

Overland Park

68526

Lincoln

75231

Dallas

78229

San Antonio

89102

Las Vegas

92056

Oceanside

92270

Rancho Mirage

92374

Redlands

92506

Riverside

02740

New Bedford

08009

Berlin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bionomics Limited

INDUSTRY